Under construction – not a live service
Sign in
Not yet taking people in United StatesNo phase

MyPatientPal+: A Smartphone App and a Provider Dashboard to Manage Patient Care While on Treatment

Key facts

Where
Detroit, United StatesSee the site

Could this be for you?

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 70 years old?

Source: NCT07928154, who can take part

Where in United States

  • Karmanos Cancer InstituteDetroit, United StatesNo longer taking part

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?
Print a page for my doctor

Trial details

Who runs it
Barbara Ann Karmanos Cancer Institute
Trial code
NCT07928154
Record updated
10 November 2026
Original description
The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effectsRead full original descriptionShow less

The overall goal of this clinical trial is to assess the feasibility of implementing MyPatientPal+ a smartphone app and provider dashboard, to collect daily patient-reported outcome data from patients and share with providers to improve the effective management of treatment-related side effects

Inclusion: Patients-; 18-70 Years of age; have a diagnosis of breast, any gastrointestinal, lung, prostate, head and neck, or bladder cancer; about to initiate chemotherapy using one of the regimens listed in the protocol; be able to speak, read, and write English; willing and able to provide consent; have access to a stable internet connection; Providers:; being a practicing oncologist; treating patients at Karmanos Cancer Institute (KCI) who are enrolled and consent to using the MyPatientPal+ smartphone app; provide consent for the study.

Exclusion: Patients-; cognitive or perceptual disturbances that prevent completing study measures Provider-; None.

ClinicalTrials.gov NCT07928154